Document:

EX-10.91

 Exhibit 10.91 
 RETENTION AGREEMENT 
 This Retention Agreement (the
“Agreement”) is entered into as of [date] by and between [Executive Name] and Hansen Medical, Inc. (the “Corporation”). 
 AGREEMENT 
 In consideration of the promises and mutual covenants set forth
herein, the parties hereby agree as follows: 
 1. Definitions. As used in this Agreement, unless the context requires a
different meaning, the following terms shall have the meanings set forth herein: 
 (a) “Board” shall mean the
Board of Directors of the Corporation 
 (b) “Cause” shall mean any of the following: (i) an intentional
unauthorized use or disclosure of the Corporation’s confidential information or trade secrets, which use or disclosure causes material harm to the Corporation, (ii) a material breach of any agreement between Executive and the Corporation,
(iii) a material failure to comply with the Corporation’s written policies or rules, (iv) conviction of, or plea of “guilty” or “no contest” to, a felony under the laws of the United States or any state thereof,
(v) gross negligence or willful misconduct or (vi) a continued failure to perform assigned duties after receiving written notification of such failure from the Board. Executive shall not be deemed to have been terminated for Cause unless
and until there shall have been delivered to Executive a Notice of Termination and copy of a resolution duly adopted by the affirmative vote of not less than three-quarters of those members of the Board who are not then employees of the Corporation
at a meeting of the Board called and held for the purpose (after reasonable notice to Executive and an opportunity for Executive, together with Executive’s counsel, to be heard before the Board), finding that, in the good faith opinion of the
Board, Executive was guilty of the conduct set forth in the first sentence of this Section 1(b) and specifying the particulars thereof in detail. 
 (c) “Change in Control” means the occurrence of any of the following events: 
 (i) a transaction or series of transactions (other than an offering of the Corporation’s Common Stock to the general public through a registration statement filed with the Securities and Exchange
Commission) whereby any “person” or related “group” of “persons”, as such terms are used in Sections 13(d) and 14(d)(2) of the Exchange Act (other than the Corporation, any of its subsidiaries, an employee benefit plan
maintained by the Corporation or any of its subsidiaries or a “person” that, prior to such transaction, directly or indirectly controls, is controlled by, or is under common control with, the Corporation) directly or indirectly acquires
beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act) of securities of the Corporation possessing more than 50% of the total combined voting power of the Corporation’s securities outstanding immediately after such
acquisition; or 
 (ii) During any period of two consecutive years, individuals who, at the beginning of such period,
constitute the Board together with any new director(s) (other than a director designated by a person who shall have entered into an agreement with the Corporation to effect a transaction described in Section 1(c)(i) or Section 1(c)(iii))
whose election by the Board or nomination for election by the Corporation’s stockholders was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of the two-year period or
whose election or nomination for election was previously so approved, cease for any reason to constitute a majority thereof; or 

  
 1 

 (iii) The consummation by the Corporation (whether directly involving the Corporation or
indirectly involving the Corporation through one or more intermediaries) of (x) a merger, consolidation, reorganization, or business combination or (y) a sale or other disposition of all or substantially all of the Corporation’s
assets in any single transaction or series of related transactions, in each case, other than a transaction: 

(A) Which results in the Corporation’s voting securities outstanding immediately before the transaction continuing
to represent (either by remaining outstanding or by being converted into voting securities of the Corporation or the person that, as a result of the transaction, controls, directly or indirectly, the Corporation or owns, directly or indirectly, all
or substantially all of the Corporation’s assets or otherwise succeeds to the business of the Corporation (the Corporation or such person, the “Successor Entity”)) directly or indirectly, at least a majority of the combined
voting power of the Successor Entity’s outstanding voting securities immediately after the transaction, and 
 (B) After which no person or group beneficially owns voting securities representing 50% or more of the combined voting power of the Successor Entity; provided, however, that no person or group shall be
treated for purposes of this Section 1(c)(iii)(B) as beneficially owning 50% or more of combined voting power of the Successor Entity solely as a result of the voting power held in the Corporation prior to the consummation of the transaction.

 (d) “COBRA” shall mean the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended. 

(e) “COBRA Coverage” shall mean the coverage under the Corporation’s medical, dental and/or vision benefit plans
that Executive and/or Executive’s eligible dependents participates following a termination of employment pursuant to COBRA. 
 (f) “Code” shall mean the Internal Revenue Code of 1986, as amended. 
 (g) “Covered Termination” shall mean (i) an Involuntary Termination Without Cause or (ii) a voluntary termination of employment by Executive for Good Reason, provided that in
either case, the termination constitutes a Separation from Service. 
 (h) “Date of Termination” shall mean
(i) if Executive’s employment is terminated due to Executive’s death, the date of Executive’s death; and (ii) if Executive’s employment is terminated for any reason other than death, the date specified in the Notice of
Termination. 

  
 2 

 (i) “Employment Commencement Date” means the date Executive’s
employment commenced with the Corporation. 
 (j) “Exchange Act” shall mean the Securities Exchange Act of
1934, as amended. 
 (k) “First Payment Date” shall mean the 60th day after the Date of Termination or, if such day is not a business
day, the next business day thereafter. 
 (l) “Good Reason” shall mean Executive’s resignation due to any
of the following events which occurs without Executive’s written consent, provided that the requirements regarding advance notice and an opportunity to cure set forth below are satisfied: (i) a material diminution of Executive’s base
salary and target bonus, other than in connection with an across-the-board reduction in the compensation (which, for avoidance of doubt, may include the elimination of any bonus opportunity) of the Company’s senior management that does not
disproportionately affect Executive, (ii) a material diminution of Executive’s authority, duties or responsibilities, or (iii) a material change in the geographic location at which Executive must perform services for the Corporation
(each of (i), (ii) and (iii), a “Good Reason Condition”). In order for Executive to resign for Good Reason, Executive must provide written notice to the Corporation of the existence of the Good Reason Condition within 90 days
of the initial existence of such Good Reason Condition. Upon receipt of such notice of the Good Reason Condition, the Corporation will be provided with a period of 30 days during which it may remedy the Good Reason Condition and not be required to
provide for the payments and benefits described herein as a result of such proposed resignation due to the Good Reason Condition specified in the Notice of Termination. If the Good Reason Condition is not remedied within the period specified in the
preceding sentence, Executive may resign based on the Good Reason Condition specified in the Notice of Termination effective no later than 180 days following the initial existence of such Good Reason Condition. 

(m) “Involuntary Termination Without Cause” shall mean termination of Executive’s employment by the Corporation
other than for Cause. For purposes of this Agreement, an Involuntary Termination Without Cause shall only include a termination by the Corporation where the Executive was willing and able to continue performing services within the meaning of
Treasury Regulation Section 1.409A-1(n)(1). 
 (n) “Notice of Termination” shall mean a notice from
Executive or the Corporation to the other party regarding the intent to terminate Executive’s employment. To the extent applicable, the Notice of Termination shall indicate the specific termination provision in this Agreement (if any) relied
upon and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of Executive’s employment under the provision so indicated. 

(o) “Release” shall mean a release by Executive of all claims arising out of Executive’s employment with the
Corporation or the termination thereof, in a form reasonably acceptable to the Corporation. 

  
 3 

 (p) “Separation from Service” means Executive’s termination of
employment or service which constitutes a “separation from service” within the meaning of Treasury Regulation Section 1.409A-1(h). 
 2. Notice. 
 (a) Notice of Termination. Any termination of
Executive’s employment by the Corporation or by Executive (other than termination due to Executive’s death, which shall terminate Executive’s employment automatically) shall be communicated by a written Notice of Termination to the
other party hereto in accordance with Section 2(b) and shall set forth the Date of Termination, which shall not be earlier than the date on which the Notice of Termination is provided. 

(b) Manner of Notice. For purposes of this Agreement, a Notice of Termination, as well as other notices and communications
provided for in this Agreement, shall be in writing and shall be deemed to have been duly given when delivered or mailed by United States certified or registered mail, return receipt requested, postage prepaid, addressed to the Corporation at its
principal office or to Executive at the address in the Corporation’s payroll records, provided that all notices to the Corporation shall be directed to the attention of its Secretary, or to such other address as either party may have furnished
to the other in writing in accordance herewith, except that notice of change of address shall be effective only upon receipt. 

3. Compensation upon Certain Terminations. 
 (a) Termination for Any Reason. Upon Executive’s termination of employment with the Corporation for any reason, Executive shall be paid all amounts earned or accrued but unpaid as of the
Executive’s termination of employment, including (i) base salary, (ii) reimbursement for reasonable and necessary expenses incurred by the Executive on behalf of the Corporation during the period ending on the date of termination,
(iii) pay for unused vacation time, (iv) any bonuses and incentive compensation earned through the date of termination, and (v) reimbursement for any unused amounts deposited in the Corporation’s ESPP. 

(b) Covered Termination Prior to a Change in Control or More Than Twelve Months After a Change in Control. If Executive’s
employment with the Corporation is terminated not less than six (6) months after the Employment Commencement Date due to a Covered Termination which occurs prior to a Change in Control or more than twelve (12) months following a Change in
Control, and Executive executes and does not revoke a Release as described in Section 3(d) below, then Executive shall be entitled to the following severance benefits: 
 (i) Severance Payment. If the Date of Termination is less than one (1) year but not less than six (6) months after the Employment Commencement Date, Executive shall be entitled to
severance payments equal to three (3) months’ worth of the Executive’s then-current annual base salary (commencing as of the Date of Termination), and if the Date of Termination is not less than one (1) year after the Employment
Commencement Date, Executive shall be entitled to severance payments equal to six (6) months’ worth of the Executive’s then-current annual base salary (commencing as of the Date of Termination). Severance payments shall be paid in
accordance with the Corporation’s normal payroll procedures beginning on the First Payment Date, except that any payments that would otherwise have been made before the First Payment Date shall be made on the First Payment Date. 

  
 4 

 (ii) Continued Benefits. If the Date of Termination is less than one (1) year
but not less than six (6) months after the Employment Commencement Date, the Corporation shall pay COBRA Coverage for Executive and Executive’s dependents for the period beginning on the Date of Termination and extending through the
earlier of either (A) three (3) months from the Date of Termination, or (B) the first day of Executive’s eligibility to participate in a comparable group health plan maintained by a subsequent employer. If the Date of Termination
is not less than one (1) year after the Employment Commencement Date, the Corporation shall pay COBRA Coverage for Executive and Executive’s dependents for the period beginning on the Date of Termination and extending through the earlier
of either (A) six (6) months from the Date of Termination, or (B) the first day of Executive’s eligibility to participate in a comparable group health plan maintained by a subsequent employer. 

(c) Covered Termination Within Twelve Months After a Change in Control. If Executive’s employment with the Corporation is
terminated due to a Covered Termination which occurs within twelve (12) months following a Change in Control, and Executive executes and does not revoke a Release as described in Section 3(d) below, then Executive shall be entitled to the
following severance benefits: 
 (i) Acceleration of Equity Awards. Executive shall become vested with respect to one
hundred percent (100%) of the unvested portion of any options to purchase the Corporation’s capital stock that Executive then holds and the restrictions with respect to one hundred percent (100%) of any restricted share award,
restricted stock unit award or other equity award with regard to the Corporations’ capital stock that Executive then holds shall immediately lapse. 
 (ii) Severance Payment. Executive shall be entitled to severance payments equal to six (6) months worth of the Executive’s then-current annual base salary (commencing as of the Date of
Termination) and a pro rated portion of Executive’s annual target bonus for the same period, which payments shall be paid in accordance with the Corporation’s normal payroll procedures beginning on the First Payment Date, except that any
payments that would otherwise have been made before the First Payment Date shall be made on the First Payment Date. 
 (iii)
Continued Benefits. For the period beginning on the Date of Termination and extending through the earlier of either (A) six (6) months from the Date of Termination, or (B) the first day of Executive’s eligibility to
participate in a comparable group health plan maintained by a subsequent employer, the Corporation shall pay COBRA Coverage for Executive and Executive’s dependents. 
 (d) Release. As a condition to Executive’s receipt of any benefits described in this Section 3 (other than in Section 3(a)), Executive shall be required to execute a Release
within fifty (50) days following the Date of Termination and not revoke such Release within any period permitted under applicable law. Such Release shall specifically relate to all of Executive’s rights and claims in existence at the time
of such execution but shall exclude any continuing obligations the Corporation may have to Executive following the date of termination under this Agreement or any other agreement providing for obligations to survive Executive’s termination of
employment. 

  
 5 

 4. Section 409A. Notwithstanding any provision to the contrary in this
Agreement, if Executive is deemed by the Corporation at the time of his Separation from Service to be a “specified employee” for purposes of Section 409A(a)(2)(B)(i) of the Code, to the extent delayed commencement of any portion of
the benefits to which Executive is entitled under this Agreement is required in order to avoid a prohibited distribution under Section 409A(a)(2)(B)(i) of the Code, such portion of Executive’s benefits shall not be provided to Executive
prior to the earlier of (a) the expiration of the six-month period measured from the date of Executive’s Separation from Service or (b) the date of Executive’s death. Upon the first business day following the expiration of the
applicable Code Section 409A(a)(2)(B)(i) period, all payments deferred pursuant to this Section 4 shall be paid in a lump sum to Executive, and any remaining payments due under the Agreement shall be paid as otherwise provided herein. For
purposes of Section 409A of the Code (including, without limitation, for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii)), Executive’s right to receive any installment payments payable hereunder shall be treated as a right
to receive a series of separate payments and, accordingly, each such installment payment shall at all times be considered a separate and distinct payment. 
 5. Excise Tax Limitation. 
 (a) Notwithstanding anything contained in this
Agreement to the contrary, in the event that the benefits provided by this Agreement, together with all other payments and the value of any benefits received or to be received by Executive (“Payments”), constitute “parachute
payments” within the meaning of Section 280G of the Code, and, but for this Section 5, would be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then the Payments shall be made to
Executive either (i) in full or (ii) as to such lesser amount as would result in no portion of the Payments being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local
income taxes and the Excise Tax, results in the receipt by Executive on an after-tax basis, of the greatest amount of benefits, notwithstanding that all or some portion of the Payments may be subject to the Excise Tax. The Corporation shall reduce
or eliminate the Payments by first reducing or eliminating cash payments and then by reducing those payments or benefits which are not payable in cash, in each case in reverse order beginning with payments or benefits which are to be paid the
farthest in time from the Determination (as hereinafter defined). 
 (b) Unless the Corporation and Executive otherwise agree in
writing, an initial determination as to whether the Payments shall be reduced and the amount of such reduction shall be made, at the Corporation’s expense, by the accounting firm that is the Corporation’s independent accounting firm as of
the date of the Change in Control (the “Accounting Firm”). The Accounting Firm shall provide its determination (the “Determination”), together with detailed supporting calculations and documentation, to the
Corporation and Executive within twenty (20) days of the Date of Termination if applicable, or such other time as requested by the Corporation or by Executive (provided Executive reasonably believes that Executive will receive Payments which
may be subject to the Excise Tax), and if the Accounting Firm determines that there is substantial authority (within the meaning of Section 6662 of the Code) that no Excise Tax is payable by Executive with respect to a Payment or Payments, it
shall furnish Executive with an opinion reasonably acceptable to Executive that no Excise Tax will be imposed with respect to any such Payment or Payments. Within ten (10) days of the delivery of the Determination to Executive, Executive shall
have the right to dispute the Determination (the “Dispute”). If there is no Dispute, the Determination shall be binding, final and conclusive upon the Corporation and Executive. 

  
 6 

 (c) As a result of the uncertainty in the application of Sections 4999 and 280G of the Code,
it is possible that the Payments to be made to, or provided for the benefit of, Executive either will be greater (an “Excess Payment”) or less (an “Underpayment”) than the amounts provided for by the limitation
contained in Section 5(a). 
 (i) If it is established pursuant to a final determination of a court or an Internal Revenue
Service (the “IRS”) proceeding which has been finally and conclusively resolved that an Excess Payment has been made, such Excess Payment shall be deemed for all purposes to be a loan to Executive made on the date Executive received
the Excess Payment and Executive shall repay the Excess Payment to the Corporation on demand (but not less than ten (10) days after written notice is received by Executive) together with interest on the Excess Payment at the “Applicable
Federal Rate” (as defined in Section 1274(d) of the Code) from the date of Executive’s receipt of such Excess Payment until the date of such repayment. 
 (ii) In the event that it is determined by (A) the Accounting Firm, the Corporation (which shall include the position taken by the Corporation, or together with its consolidated group, on its federal
income tax return) or the IRS, (B) pursuant to a determination by a court, or (C) upon the resolution to Executive’s satisfaction of the Dispute that an Underpayment has occurred, the Corporation shall pay an amount equal to the
Underpayment to Executive within ten (10) days of such determination or resolution, together with interest on such amount at the Applicable Federal Rate from the date such amount would have been paid to Executive until the date of payment.

 6. Successors; Binding Agreement. 
 (a) The Corporation shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Corporation
to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Corporation would be required to perform it if no such succession had taken place. Unless expressly provided otherwise,
“Corporation” as used herein shall mean the Corporation as defined in this Agreement and any successor to its business and/or assets as aforesaid. 
 (b) This Agreement shall inure to the benefit of and be enforceable by Executive and Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees,
devisees and legatees. If Executive should die while any amount would still be payable to Executive hereunder had Executive continued to live, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this
Agreement to Executive’s devisee, legatee or other designee or, if there is no such designee, to Executive’s estate. 

  
 7 

 7. Miscellaneous. 

(a) Modification or Amendment. No provision of this Agreement may be modified or amended unless such modification or amendment is
agreed to in writing and signed by Executive and an authorized officer of the Corporation as may be specifically designated by the Board or a committee thereof. 
 (b) Waiver. No waiver by either party hereto at any time of any breach by the other party hereto of or compliance with, any condition or provision of this Agreement to be performed by such other
party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time. 
 (c) Complete Agreement. This Agreement constitutes the entire agreement between Executive and the Corporation and is the complete, final and exclusive embodiment of their agreement with regard to
this subject matter, and this Agreement shall supersede any prior or contemporaneous written or oral agreements regarding this subject matter. No agreements or representations, oral or otherwise, express or implied, with respect to the subject
matter hereof have been made by either party which are not expressly set forth in this Agreement. 
 (d) Non-Exclusivity of
Rights. Notwithstanding Section 7(c), nothing in this Agreement shall prevent or limit Executive’s continuing or future participation in any benefit, bonus, incentive or other plan or program provided by the Corporation (except for any
severance or termination policies, plans, programs or practices) and for which Executive may qualify, nor shall anything herein limit or reduce such rights as Executive may have under any other agreements with the Corporation (except for any
severance, termination or other agreement regarding the subject matter of this Agreement). Amounts which are vested benefits or which Executive is otherwise entitled to receive under any plan or program of the Corporation shall be payable in
accordance with such plan or program, except as explicitly modified by this Agreement. 
 (e) Governing Law. The
validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the State of California without regard to its conflicts of law principles. 

(f) Statutory References. All references to sections of the Exchange Act or the Code shall be deemed also to refer to any
successor provisions to such sections. 
 (g) Tax Withholding. Any payments provided for hereunder shall be paid net of
any applicable withholding required under federal, state or local law. 
 (h) Section Headings. The section headings
contained in this Agreement are for convenience only, and shall not affect the interpretation of this Agreement. 

  
 8 

 (i) Severability. The invalidity or unenforceability of any provision of this
Agreement shall not affect the validity or enforceability of any other provision of this Agreement, which shall remain in full force and effect. 
 (j) Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original but all of which together shall constitute one and the same instrument.

 8. Arbitration. The parties hereby agree that any and all claims or controversies regarding this Agreement shall be
resolved, to the fullest extent permitted by law, by final, binding and confidential arbitration in Palo Alto, California conducted before a single arbitrator by Judicial Arbitration and Mediation Services/Endispute (“JAMS”) or its
successor, under the then applicable JAMS rules. By agreeing to this arbitration procedure, both parties waive the right to resolve any such dispute through a trial by jury or judge or by administrative proceeding. The arbitrator shall:
(a) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (b) issue a written arbitration decision including the arbitrator’s essential
findings and conclusions and a statement of the award. The Corporation shall pay all of JAMS’ arbitration fees. Nothing in this Agreement shall prevent either party from obtaining injunctive relief in court if necessary to prevent irreparable
harm pending the conclusion of any arbitration. 
 9. Fees and Expenses. In connection with a Covered Termination which
occurs within twelve (12) months after a Change in Control, the Corporation shall pay all reasonable legal fees and related expenses (including the costs of experts, evidence and counsel) incurred by Executive as they become due as a result of
(a) Executive seeking to obtain or enforce any right or benefit provided by this Agreement (including, but not limited to, any such fees and expenses incurred in connection with the Dispute whether as a result of any applicable government
taxing authority proceeding, audit or otherwise), and (b) Executive’s hearing before the Board as contemplated in Section 1(b) of this Agreement. To the extent that any reimbursements payable to Executive pursuant to this
Section 9 are subject to the provisions of Section 409A of the Code, such reimbursements shall be paid to Executive no later than December 31 of the year following the year in which the cost was incurred, the amount of expenses
reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year, and Executive’s right to reimbursement under this Section 9 will not be subject to liquidation or exchange for another benefit.

 10. Settlement of Claims. The Corporation’s obligation to make the payments provided for in this Agreement and
otherwise to perform its obligations hereunder shall not be affected by any circumstances, including, without limitation, any set-off, counterclaim, recoupment, defense or other right which the Corporation may have against Executive or others.

 11. At-Will Employment. Nothing contained in this Agreement shall (a) confer upon Executive any right to continue
in the employ of the Corporation, (b) constitute any contract or agreement of employment, or (c) interfere in any way with the at-will nature of Executive’s employment with the Corporation. 

  
 9 

 12. Miscellaneous. The Corporation shall not be required to fund or otherwise
segregate assets to be used for the payment of any benefits under this Agreement. The Corporation shall make such payments only out of its general corporate funds, and therefore its obligation to make such payments shall be subject to any claims of
its other creditors having priority as to its assets. 
 IN WITNESS WHEREOF, the parties have executed this Agreement as of the
Effective Date. 
  

			
	EXECUTIVE
	
	  

	[Executive Name]
	
	HANSEN MEDICAL, INC.
	
	  

	By:	 	Bruce J Barclay
		 	President and CEO

  
 10EX-10.1

 Exhibit 10.1 
 March 26, 2013 
 VIA HAND
DELIVERY 
 William Densel 
 109 Austin Road 
 Sudbury, Massachusetts 01776 

 

	 	Re:	Severance Agreement and Release 

 Dear
Bill: 
 This letter agreement (hereinafter the “Agreement”) confirms the terms of your
separation from BG Medicine, Inc. (“BG Medicine” or “Company”). The consideration described below is contingent on your agreement to and compliance with the terms of this Agreement. The Effective Date of this Agreement shall be
the eighth (8th) day following the day that you sign
it, as described more fully in Section 10 below. 
  

	 	1.	Employment Status and Final Payments: 

 (a) Your termination from employment with the Company shall be effective as of March 26, 2013 (the “Termination Date”). As of the Termination Date, your salary shall cease, and any
entitlement you have or might have under a Company-provided benefit plan, program, contract or practice shall terminate, except as required by federal or state law, or as otherwise described below. 

(b) You hereby acknowledge that as of the Termination Date, you have been paid all wages earned but unpaid and have been paid for all
vacation time accrued but unused as of the Termination Date. 
 (c) The Termination Date shall be the date of the
“qualifying event” under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”) and the Company shall present you with information on COBRA under separate cover. 

(d) You acknowledge that as of the Termination Date, you are not currently vested in stock options, and that following the Termination
Date, you shall not have any further rights to vest in any stock options under any Company stock or stock option plan (of whatever name or kind) that you may have participated in or were eligible to participate in during your employment. 

(e) You and the Company agree that if a third party requests information from a member of the Company’s executive team regarding
your separation of employment, then such executive team member shall state that you voluntarily resigned to pursue outside opportunities. 

 2. Consideration: In exchange for the mutual covenants set forth in this
Agreement, and beginning as soon as practicable after the Effective Date of this Agreement, the Company agrees to provide you with the following consideration: 
 (a) Severance Pay: Severance pay in the form of payments equal to six (6) months of your original base salary, less state, federal and/or local income and welfare taxes and any other mandatory
deductions under applicable laws, paid in accordance with the Company’s payroll practices over a six (6) month period following the Effective Date. 
 (b) Health Insurance: If you elect to continue medical and dental insurance coverage after the Termination Date in accordance with the provisions of the Consolidated Omnibus Budget Reconciliation
Act of 1985 (“COBRA”), then the Company shall pay your monthly premium payments, less the employee contribution, for six (6) months following your Termination Date, on the same terms that such insurance plans are provided to persons
currently employed by the Company. Thereafter, medical and dental insurance coverage shall be continued only to the extent required by COBRA and only to the extent you timely pay the premium payments yourself. All other benefits shall cease as of
the Termination Date. 
 You acknowledge and agree that the consideration provided herein is not otherwise due or owing to you
under any Company policy or practice, nor is this consideration intended to, and shall not, constitute a severance plan, and shall confer no benefit on anyone other than the parties hereto. 

3. Release: 
 (a) Release. In exchange for the payments and benefits described in Section 2, which are in addition to anything of value to which you are entitled to receive, and other good and valuable
consideration, the sufficiency of which is hereby acknowledged, you and your representatives, agents, estate, heirs, successors and assigns, absolutely and unconditionally hereby release, remise, discharge, indemnify and hold harmless the Company
Releasees (defined to include the Company and/or any of its parents, subsidiaries or affiliates, predecessors, successors or assigns, and its and their respective current and/or former partners, directors, shareholders/stockholders, officers,
employees, attorneys and/or agents, all both individually and in their official capacities), from any and all actions or causes of action, suits, claims, complaints, contracts, liabilities, agreements, promises, torts, debts, damages, controversies,
judgments, rights and demands, whether existing or contingent, known or unknown, suspected or unsuspected, which arise out of your employment with, change in employment status with, and/or separation of employment from, the Company. This release is
intended by you to be all encompassing and to act as a full and total release of any claims, whether specifically enumerated herein or not, that you may have or have had against the Company Releasees arising from conduct occurring up to and through
the date of this Agreement, including, but not limited to: 
 (i) Claims under any Massachusetts (or any other state) or federal
statute, regulation or executive order (as amended through the Separation Date) relating to employment, discrimination, fair employment practices, or other terms and conditions of employment, including but not limited to the Age
Discrimination in Employment Act and Older Workers Benefit Protection Act (29 U.S.C. § 621 et seq.), the Civil Rights Acts of 1866 and 1871 and Title VII of the Civil Rights Act of 1964 and the Civil Rights Act of 1991 (42 U.S.C.
§ 2000e et seq.), the Equal Pay Act (29 U.S.C. § 201 et seq.), the Americans With Disabilities Act (42 U.S.C. § 12101 et seq.), the Massachusetts Fair Employment Practices Statute (M.G.L. c. 151B § 1 et
seq.), the Massachusetts Equal Rights Act (M.G.L. c. 93 §102), the Massachusetts Civil Rights Act (M.G.L. c. 12 §§ 11H & 11I), and any similar Massachusetts or other state or federal statute. 

  
 2 

 (ii) Claims under any Massachusetts (or any other state) or federal statute, regulation or
executive order (as amended through the Separation Date) relating to wages, hours or other terms and conditions of employment, including but not limited to the National Labor Relations Act (29 U.S.C. § 151 et seq.), the Family and
Medical Leave Act (29 U.S.C. §2601 et seq.), the Employee Retirement Income Security Act of 1974 (29 U.S.C. § 1000 et seq.), COBRA (29 U.S.C. § 1161 et seq.), the Massachusetts Wage Act (M.G.L. c. 149 §
148 et. seq.), the Massachusetts Minimum Fair Wages Act (M.G.L. c. 151 § 1 et. seq.), the Massachusetts Equal Pay Act (M.G.L. c. 149 § 105A), and any similar Massachusetts or other state or federal statute.

(iii) Claims under any Massachusetts (or any other state) or federal common law theory, including, without limitation, wrongful
discharge, breach of express or implied contract, promissory estoppel, unjust enrichment, breach of a covenant of good faith and fair dealing, violation of public policy, defamation, interference with contractual relations, intentional or negligent
infliction of emotional distress, invasion of privacy, misrepresentation, deceit, fraud or negligence or any claim to attorneys’ fees under any applicable statute or common law theory of recovery. 

(iv) Claims under any Massachusetts (or any other state) or federal statute, regulation or executive order (as amended through the
Separation Date) relating to whistleblower protections, violation of public policy, or any other form of retaliation or wrongful termination, including but not limited to the Sarbanes-Oxley Act of 2002 and any similar Massachusetts or other state or
federal statute. 
 (v) Any other Claim arising under other state or federal law. 

You not only release and discharge the Company Releasees from any and all claims as stated above that you could make on your own behalf
or on behalf of others, but also those claims that might be made by any other person or organization on your behalf, and you specifically waive any right to recover any damage awards as a member of any class in a case in which any claim(s) against
the Company Releasees are made involving any matters. 
 (b) Release Limitation. Notwithstanding the foregoing, this
section does not: (i) release Company from any obligation expressly set forth in this Agreement, (ii) act as a waiver or release of any claims that you cannot by law waive or release, (iii) prohibit you from challenging the
validity of this release under the federal Age Discrimination in Employment Act of 1967 (“ADEA”), from filing a charge or complaint of age discrimination with the federal Equal Employment Opportunity Commission (“EEOC”) or
similar state agency, or from participating in any investigation or proceeding conducted by the EEOC or similar state agency. In addition, nothing in this release or this Agreement shall limit the Company’s right to seek immediate dismissal of
such charge or complaint on the basis that your signing of this Agreement constitutes a full release of any individual rights under the ADEA or other laws, or seek recovery from you, to the extent permitted by law, of the consideration provided to
you under this Agreement in the event that you successfully challenge the validity of this release and prevail on the merits of a claim under the ADEA or other laws. 

  
 3 

 (c) Acknowledgment. You acknowledge and agree that, but for providing this waiver and
release, you would not be receiving the consideration being provided to you under the terms of this Agreement. 
 4.
Rights and Claims Under the ADEA: 
 (a) You have been informed that since you are 40 years of age or older, you have
or might have specific rights and/or claims under the ADEA. 
 (b) In consideration for the payments and benefits described in
Section 2, which you are not otherwise eligible to receive, you specifically waive such rights and/or claims under the ADEA to the extent that such rights and/or claims arose prior to the date of this Agreement. Claims under the ADEA that arise
after this Agreement is signed are not waived. 
 (c) You were advised by the Company of your right to consult with an attorney
of your own choice prior to executing this Agreement. You acknowledge that you have not been subject to any undue or improper influence in the exercise of your free will in deciding whether to consult with counsel. 

(d) You were further advised when you were presented with the original version of this Agreement on March 26, 2013 that you have at
least twenty-one (21) days within which to consider the Agreement, until the close of business on April 16, 2013. In addition, as described more fully in Section 10 below, if you choose to accept this Agreement then you also
will have seven (7) days to revoke such acceptance if you choose to do so. 
 5. Accord and
Satisfaction: The payments set forth herein shall be complete and unconditional payment, settlement, accord and/or satisfaction with respect to all obligations and liabilities of the Company Releasees to you, including, without limitation,
all claims for back wages, salary, vacation pay, draws, incentive pay, bonuses, stock and stock options, commissions, severance pay, reimbursement of expenses, any and all other forms of compensation or benefits, attorney’s fees, or other costs
or sums. 
 6. Confidentiality and Related Covenants: You hereby agree and acknowledge the following: 

(a) That within three (3) days following the Termination Date you shall return to the Company all Company property and materials,
including but not limited to, (if applicable) personal computers, laptops, palm pilots and their equivalent, fax machines, scanners, copiers, cellular phones, Company credit cards and telephone charge cards, manuals, building keys and passes,
courtesy parking passes, diskettes, intangible information stored on diskettes, software programs and data compiled with the use of those programs, software passwords or codes, tangible copies of trade secrets and confidential information, sales
forecasts, names and addresses of Company customers and potential customers, customer lists, customer contacts, sales information, sales forecasts, memoranda, sales brochures, business or marketing plans, reports, projections, and any and all other
information or property previously or currently held or used by you that is or was related to your employment with the Company (“Company Property”). You represent that you have not and shall not take by download or otherwise any Company
Property. You agree that in the event that you discover any Company Property in your possession, whether in electronic form or otherwise, after the Termination Date, you shall immediately return such materials to the Company. 

  
 4 

 (b) That all information relating in any way to the subject matter of this Agreement,
including the terms and amounts, shall be held confidential by you and shall not be publicized or disclosed to any person (other than an immediate family member, legal counsel or financial advisor, provided that any such individual to whom
disclosure is made agrees to be bound by these confidentiality obligations), business entity or government agency (except as mandated by state or federal law). 
 (c) That you shall not make any private or public (including to the print or electronic media) statements that are professionally or personally disparaging about, or adverse to, the interests of Company
(including its officers, directors and employees) including, but not limited to, any statements that disparage any person, product, service, finances, financial condition, capability or any other aspect of the business of Company, or engage in any
conduct which is intended to harm professionally or personally the reputation of Company (including its officers, directors and employees). In exchange, the Company agrees that its executive team shall not make any private or public (including to
the print or electronic media) statements that are professionally or personally disparaging about, or adverse to, your interests, including, but not limited to, any statements that disparage your services, finances or capabilities, or engage in any
conduct which is intended to harm your professional or personal reputation. 
 (d) That the breach of any of the foregoing
covenants by you shall constitute a material breach of this Agreement and shall relieve Company of any further obligations hereunder and, in addition to any other legal or equitable remedy available to Company, shall entitle Company to recover any
monies already paid to you pursuant to Section 2 of this Agreement. 
 Notwithstanding the foregoing, nothing herein shall
prohibit or bar you from providing truthful testimony in any legal proceeding or in communicating with any governmental agency or representative or from making any truthful disclosure required, authorized or permitted under law; provided, however,
that in providing such testimony or making such disclosures or communications, you shall use your best efforts to ensure that this section is complied with to the maximum extent possible. Further notwithstanding the foregoing, as stated in
Section 3(b), nothing in this Agreement shall bar or prohibit you from contacting, seeking assistance from or participating in any proceeding before any federal or state administrative agency to the extent permitted by applicable federal, state
and/or local law. However, you nevertheless shall be prohibited to the fullest extent authorized by law from obtaining monetary damages in any agency proceeding in which you do so participate. 

7. Non-Competition; Non-Solicitation: All obligations and restrictive covenants as set forth in your BG Medicine Employee
Non-Competition, Confidentiality and Intellectual Property Agreement shall remain in full force and effect notwithstanding this Agreement. You hereby reaffirm your obligations to fully abide by the provisions of these aforementioned agreements.

 8. No Liability or Wrongdoing: Nothing in this Agreement, nor any of its terms and provisions, nor any of the
negotiations or proceedings connected with it, constitutes, shall be construed to constitute, shall be offered in evidence as, received in evidence as, and/or deemed to be evidence of, an admission of liability or wrongdoing by any and/or all of the
Company Releasees, and any such liability or wrongdoing is hereby expressly denied by each of the Company Releasees. 

  
 5 

 9. General: 
 (a) This Agreement sets forth the complete and sole agreement between the parties and supersedes any and all other agreements or understandings, whether oral or written, except for the Non-Competition,
Confidentiality and Intellectual Property Agreement between you and the Company, each of which shall remain in full force and effect in accordance with their respective terms. This Agreement may not be changed, amended, modified, altered or
rescinded except upon the express written consent of both the President of the Company and you. 
 (b) If any provision of this
Agreement, or part thereof, is held invalid, void or voidable as against public policy or otherwise, the invalidity shall not affect other provisions, or parts thereof, which may be given effect without the invalid provision or part. To this extent,
the provisions and parts thereof of this Agreement are declared to be severable. Any waiver of any provision of this Agreement shall not constitute a waiver of any other provision of this Agreement unless expressly so indicated otherwise. The
language of all parts of this Agreement shall in all cases be construed according to its fair meaning and not strictly for or against either of the parties. 
 (c) This Agreement and any claims arising out of this Agreement (or any other claims arising out of the relationship between the parties) shall be governed by and construed in accordance with the laws of
the Commonwealth of Massachusetts and shall in all respects be interpreted, enforced and governed under the internal and domestic laws of Massachusetts, without giving effect to the principles of conflicts of laws of such state. Any claims or legal
actions by one party against the other shall be commenced and maintained in a state or federal court located in Massachusetts, and you hereby submit to the jurisdiction and venue of any such court. 

(d) You represent that you have not been subject to any retaliation or any other form of adverse action by the Company Releasees for any
action taken by you as an employee of the Company or resulting from your exercise of or attempt to exercise any statutory rights recognized under federal, state or local law. 
 (e) You may not assign any of your rights or delegate any of your duties under this Agreement. The rights and benefits of this Agreement shall inure to the benefit of the Company’s successors and
assigns, and the Company may assign its rights and obligations hereunder to any person or entity that is assigned or succeeds to the Company’s business. 
 10. Effective Date: After signing this letter, you may revoke this Agreement for a period of seven (7) days following said execution. The Agreement shall not become effective or
enforceable and no payments shall be made pursuant to this Agreement until this revocation period has expired (“Effective Date”). 

  
 6 

 If this letter correctly states the agreement and understanding we have reached, please indicate your
acceptance by countersigning the enclosed copy and returning it to Stacie Rader, BG Medicine, Inc., 610N Lincoln Street, Waltham, MA 02451. 
  

			
	Very truly yours,
	
	BG Medicine, Inc.
		
	By:	 	 /s/ A. Stacie Rader

		 	A. Stacie Rader
		 	SVP, Executive Operations & Human Resources

 I REPRESENT THAT I HAVE READ THE FOREGOING AGREEMENT, THAT I FULLY UNDERSTAND THE TERMS AND
CONDITIONS OF SUCH AGREEMENT AND THAT I AM KNOWINGLY AND VOLUNTARILY EXECUTING THE SAME. IN ENTERING INTO THIS AGREEMENT, I DO NOT RELY ON ANY REPRESENTATION, PROMISE OR INDUCEMENT MADE BY THE COMPANY OR ITS REPRESENTATIVES WITH THE EXCEPTION OF THE
CONSIDERATION DESCRIBED IN THIS DOCUMENT. 
  

	
	Accepted and Agreed to:
	
	 /s/ William Densel

	William Densel
	
	 4/4/13

	Date

  
 7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00217-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00217-of-00352.parquet"}]]